Back to Search Start Over

First case report of PLA2R-related monotypic (IgG-κ positive) membranous nephropathy concurrent with leukocyte chemotactic factor 2 amyloidosis.

Authors :
Xu, Jing
Wang, Xinlu
Weng, Qinjie
Feng, Xiaobei
Pan, Xiaoxia
Source :
BMC Nephrology; 9/26/2023, Vol. 24 Issue 1, p1-7, 7p
Publication Year :
2023

Abstract

Background: Membranous nephropathy (MN) is a major pattern of nephrotic syndrome (NS) in adults. Some MN have secondary causes and some may be accompanied with other glomerular diseases. MN patients coexisting with amyloidosis are very rare, and mostly was polytypic MN. Herein, we describe the first report which identifying monotype PLA2R-MN (κ light chain) concurrent with leukocyte chemotactic factor 2 amyloidosis (ALECT2). This rare case highlights the importance of renal pathology for diagnosis. Case presentation: We describe a case of a 60-year-old male patient with persistent proteinuria and low serum albumin for nine months. No monoclonal component was revealed by serum and urine immunofixation electrophoresis but serum PLA2R antibody was positive. The patient was empirically treated with Leflunomide and Losartan, but edema was not improved. The diagnosis of renal pathology is PLA2R-related monotypic (IgG-κ positive) MN concurrent with ALECT2. Methylprednisolone, cyclosporine A and anticoagulant (rivaroxaban) were prescribed resulting in a complete remission of NS. Conclusions: MN patients concurrent with ALECT2 presented massive proteinuria or NS. When nephrotic range proteinuria is present in ALECT2, it is important to consider that it may be due to a concomitant underlying nephropathy especially MN and treated according to MN will get good therapeutic effect. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14712369
Volume :
24
Issue :
1
Database :
Complementary Index
Journal :
BMC Nephrology
Publication Type :
Academic Journal
Accession number :
172342743
Full Text :
https://doi.org/10.1186/s12882-023-03331-x